ESR1 and metabolic dysfunction-associated steatohepatitis: Estrogens decrease liver cholesterol and triglyceride concentrations only in females [31], while tamoxifen, a potent estrogen receptor antagonist, causes severe steatosis progressing towards NASH [32].